Related Experiment Video
Updated: Dec 28, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
Targeted nanopore sequencing with Cas9-guided adapter ligation
Timothy Gilpatrick1, Isac Lee1, James E Graham2
1Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Nanopore Cas9-targeted sequencing (nCATS) offers high-depth sequencing and comprehensive variant detection. This method simultaneously assesses single-nucleotide variants, structural variations, and CpG methylation with low DNA input.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Current sequencing methods face limitations in achieving high depth and detecting diverse variants.
- Existing assays often struggle with native modification preservation, read length, input DNA requirements, yield, or protocol duration.
Purpose of the Study:
- To introduce nanopore Cas9-targeted sequencing (nCATS) as an advanced enrichment strategy.
- To demonstrate nCATS' capability for simultaneous haplotype-resolved variant detection and methylation analysis.
Main Methods:
- nCATS utilizes targeted DNA cleavage by Cas9 for adapter ligation in nanopore sequencing.
- The method was applied to various samples including cell lines, xenografts, and primary human breast tissues.
Main Results:
- nCATS achieved high median sequencing coverage (675× on MinION, 34× on Flongle).
- The technique requires minimal genomic DNA input (~3 μg) and can target numerous loci concurrently.
- Simultaneous assessment of single-nucleotide variants, structural variations, and CpG methylation was demonstrated.
Conclusions:
- nCATS provides a powerful tool for high-depth, comprehensive variant detection and epigenetic analysis.
- This method enhances the utility of long-read sequencing for both research and clinical applications.
More Related Videos
11:37Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
Published on: February 26, 2019
08:22CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018